NCT06430151

Brief Summary

The CUE1 device is a non-invasive wearable device for people with Parkinson's Disease (PD) approved for sale in the UK. The CUE1 device utilises two established methods to improve motor symptoms in PD, namely pulsed cueing and vibrotactile stimulation. Many people with PD wish to explore non-pharmacological interventions as an adjunct to manage their motor symptom. Study design and eligibility: This feasibility study is to establish whether the CUE1 device is a useable and acceptable device for older people with PD. 20-25 participants aged \>60 years with PD will be recruited from a movement disorder service to the study. Methodology: Participants will undertake baseline assessments of motor symptoms and quality of life with a PD nurse assessor in their own home. Following this the CUE1 device will be fitted and repeat assessments of motor symptoms will take place after 20 minutes. The participants will complete a daily diary of useability and acceptability for 4 weeks. A second visit will occur at 4 weeks with the same PD nurse assessor where the final set of motor symptom and quality of life assessments will be completed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

May 16, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 28, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2024

Completed
Last Updated

May 28, 2024

Status Verified

May 1, 2024

Enrollment Period

6 months

First QC Date

May 16, 2024

Last Update Submit

May 21, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Useability and acceptability of the CUE1 device in older people with Parkinson's disease

    Participants' completion of a patient diary which will collect safety, tolerability, useability, and efficacy reports of the device over the study period. Participants will also complete a Patient Global Impression of Change (PGI-C) questionnaire at the end of the study.

    4 weeks

Secondary Outcomes (1)

  • To undertake standardized, validated measurements of motor function with use of the CUE1 device

    4 weeks

Study Arms (1)

CUE1 users

EXPERIMENTAL
Device: CUE1

Interventions

CUE1DEVICE

Sternal worn focused vibrotactile stimulation and cueing device

CUE1 users

Eligibility Criteria

Age60 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Individuals under the care of a Cambridge University Hospitals Foundation Trust movement disorder service with an established clinical diagnosis of Parkinson's disease based on the UK Brain bank criteria

You may not qualify if:

  • Co-existing significant neurological disorder (disabling stroke, multiple sclerosis, dementia, motor neurone disease),
  • Atypical parkinsonian disorder diagnosis (e.g. multiple systems atrophy, progressive supranuclear palsy or cortical basal degeneration syndrome)
  • co-existing physical impairment or disability causing significant mobility impairment (severe lower limb osteoarthritis)
  • trauma or pain to the sternum
  • use of other medical device e.g. pacemaker, deep brain stimulator, TENS machine etc
  • lacking capacity to consent to the study
  • Sensitivity to medical adhesives
  • Existing participant in intervention research trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cambridge University Hospitals Foundation Trust

Cambridge, United Kingdom

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Alistair J Mackett, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Useability and acceptability study of a vibrotactile stimulation device
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Consultant Geriatrician

Study Record Dates

First Submitted

May 16, 2024

First Posted

May 28, 2024

Study Start

May 16, 2024

Primary Completion

November 16, 2024

Study Completion

December 16, 2024

Last Updated

May 28, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

No plans to make IPD available to other researchers

Locations